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HIV resistance to approved therapeutics is an increasing
concern necessitating the need for development of new
therapeutic approaches. Elusys's novel Heteropolymer
(HP) technology consists of two monoclonal antibodies
that are chemically cross-linked: one specific for comple-
ment receptor type 1 (CR1, CD35) on red blood cells
(RBCs) and the other recognizing the target pathogen.
Previous studies with multiple families of viruses have
demonstrated that administration of HPs leads to rapid
immobilization of virus to RBCs followed by delivery to
the Kupffer cells of the liver where the viruses were
destroyed.
Two different HIV HPs with distinct gp120 binding specif-
icities were generated and shown to simultaneously bind
to transgenic mouse (TgN) RBCs (expressing human CR1)
and gp120 in vitro by FACS analysis. Both HIV HPs were
able to reduce the circulation in plasma of inactivated HIV
more rapidly than the corresponding HIV Mabs in the
TgN mouse. Both HIV HPs neutralized HIV strains SF162
and NL4-3 while only HIV HP 2 was able to neutralize
SHIV89.6P.
These results support Elusys continuing efforts and testing
of HIV HP as a new therapeutic approach.
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